Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
24 results for “clinic”
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
A quick rundown of the highlights so far, and what’s still left to look forward to.
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
We unpack the science behind the ECS and its significance in a range of chronic conditions.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
Jordan Stephens aims to shed light on the role of alternative treatments in supporting mental wellbeing.
The Medical Cannabis Clinicians Society (MCCS) and Curaleaf Laboratories have formed a new partnership aimed at addressing critical knowledge gaps.
Cannabis Health has partnered with experts at the Medical Cannabis Clinicians Society to host its first event for healthcare professionals.
A substantial number of patients’ details, including prescription information, were found on a file hosting website.
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing […]
Cannabis clinics can play a crucial role in changing this landscape by setting high professional standards and ensuring patients receive the same level of care as with any other medical treatment.
The FDA has given MAPS the green light to carry out a study in 320 veterans suffering from moderate to severe PTSD.
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major […]
Synthetic THC (dronabinol) was well tolerated by patients without adverse effects seen from current medications.
The partnership aims to improve treatment options available to patients with chronic pain.
Experts are urging clinics to follow best practice guidelines as the industry reaches a ‘tipping point’.
Researchers have published findings from one of the first clinical trials on CBG in humans.
The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Treat It clinic.
Leaders have assured patients that all aspects of operations, services, and leadership will remain unchanged.
In a landmark new collaboration, the CBD by BRITISH CANNABIS™ range of pharmacy-quality CBD food supplements is set to become available on prescription to pain patients for the first time […]
A cannabis charity raised over €400,000 to make the trial possible.
The Australian clinic, which is said to have helped hundreds of thousands of patients access medical cannabis, is now launching in the UK. AlternaLeaf, a private clinic which has been […]